Trial Profile
A Phase 1 Study to Evaluate the Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of GS-5801, and theEffect of Food on GS-5801 Pharmacokinetics in Healthy Subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs GS 5801 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 08 Jan 2018 Status changed from not yet recruiting to discontinued.
- 27 Sep 2016 New trial record